|Bid||144.97 x 900|
|Ask||145.74 x 900|
|Day's Range||141.61 - 145.40|
|52 Week Range||125.77 - 174.16|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||9.65|
|Forward Dividend & Yield||2.64 (1.82%)|
|Ex-Dividend Date||Jun 03, 2022|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for DGX
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Adding defensive healthcare stocks can be a great way to ride out continued volatility in the market. AbbVie (ABBV): Investors are overreacting to this venerable big pharma company’s recent earnings report. Amgen (AMGN): An established biotech company with a high forward dividend yield (3.33%). Baxter International (BAX): A reasonably-priced medical products provider on track to deliver strong results. Quest Diagnostics (DGX): Focus will soon shift to the evergreen nature of its main testing bus